| Literature DB >> 18245832 |
Annick Breton1, Benoît Pinson, Fanny Coulpier, Marie-France Giraud, Alain Dautant, Bertrand Daignan-Fornier.
Abstract
Guanylic nucleotide biosynthesis is a conserved and highly regulated process. Drugs reducing GMP synthesis affect the immunological response and mutations enabling guanylic-derivative recycling lead to severe mental retardation. While the effects of decreased GMP synthesis have been well documented, the consequences of GMP overproduction in eukaryotes are poorly understood. In this work, we selected and characterized several mutations making yeast hypoxanthine-guanine phosphoribosyltransferase insensitive to feedback inhibition by GMP. In these mutants, accumulation of guanylic nucleotides can be triggered by addition of extracellular guanine. We show that such an accumulation is highly toxic for yeast cells and results in arrest of proliferation and massive cell death. This growth defect could be partially suppressed by overexpression of Rfx1p, a transcriptional repressor of the DNA damage response pathway. Importantly, neither guanylic nucleotide toxicity nor its suppression by Rfx1p was associated with an alteration of forward mutation frequency.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18245832 PMCID: PMC2248339 DOI: 10.1534/genetics.107.083295
Source DB: PubMed Journal: Genetics ISSN: 0016-6731 Impact factor: 4.562